BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 21613441)

  • 1. Congenital heart disease: cardiovascular MR imaging by using an intravascular blood pool contrast agent.
    Makowski MR; Wiethoff AJ; Uribe S; Parish V; Botnar RM; Bell A; Kiesewetter C; Beerbaum P; Jansen CH; Razavi R; Schaeffter T; Greil GF
    Radiology; 2011 Sep; 260(3):680-8. PubMed ID: 21613441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadofosveset trisodium-enhanced magnetic resonance angiography of the left atrium--a feasibility study.
    Wagner M; Rief M; Asbach P; Vogtmann T; Huppertz A; Beling M; Butler C; Laule M; Warmuth C; Taupitz M; Hamm B; Lembcke A
    Eur J Radiol; 2010 Aug; 75(2):166-72. PubMed ID: 19464133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents.
    Maki JH; Wang M; Wilson GJ; Shutske MG; Leiner T
    J Magn Reson Imaging; 2009 Nov; 30(5):1085-92. PubMed ID: 19856442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.
    Frydrychowicz A; Russe MF; Bock J; Stalder AF; Bley TA; Harloff A; Markl M
    Acad Radiol; 2010 Nov; 17(11):1394-400. PubMed ID: 20650665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T1 contrast in the myocardium and blood pool: a quantitative assessment of gadopentetate dimeglumine and gadofosveset trisodium at 1.5 and 3 T.
    Lin K; Lloyd-Jones DM; Spottiswoode B; Bi X; Liu Y; Lu B; Xue H; Wang Y; Li D; Carr JC
    Invest Radiol; 2014 Apr; 49(4):243-8. PubMed ID: 24473364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine.
    Klessen C; Hein PA; Huppertz A; Voth M; Wagner M; Elgeti T; Kroll H; Hamm B; Taupitz M; Asbach P
    Invest Radiol; 2007 Sep; 42(9):659-64. PubMed ID: 17700282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac magnetic resonance angiography using blood-pool contrast agents: comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosveset trisodium in pigs.
    Schnorr J; Taupitz M; Schellenberger EA; Warmuth C; Fahlenkamp UL; Wagner S; Kaufels N; Wagner M
    Rofo; 2012 Feb; 184(2):105-12. PubMed ID: 22179768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium.
    Iezzi R; Soulez G; Thurnher S; Schneider G; Kirchin MA; Shen N; Pirovano G; Spinazzi A
    Eur J Radiol; 2011 Feb; 77(2):358-68. PubMed ID: 19679417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison.
    Schneider G; Pasowicz M; Vymazal J; Seidl Z; Aschauer M; Konopka M; Bilecen D; Iezzi R; Ballarati C
    AJR Am J Roentgenol; 2010 Aug; 195(2):476-85. PubMed ID: 20651208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis: contrast-enhanced MR imaging of vessel wall in rabbit model--comparison of gadofosveset and gadopentetate dimeglumine.
    Lobbes MB; Miserus RJ; Heeneman S; Passos VL; Mutsaers PH; Debernardi N; Misselwitz B; Post M; Daemen MJ; van Engelshoven JM; Leiner T; Kooi ME
    Radiology; 2009 Mar; 250(3):682-91. PubMed ID: 19244042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic blood pool contrast agent-enhanced whole-body MR angiography for treatment planning in patients with significant arterial stenosis.
    Huppertz A; Kroll H; Klessen C; Taupitz M; Rückert RI; Schröder RJ; Albrecht T; Frericks B; Voth M; Wagner M; Hamm B; Asbach P
    Invest Radiol; 2009 Jul; 44(7):422-32. PubMed ID: 19448555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital heart disease in adults: Quantitative and qualitative evaluation of IR FLASH and IR SSFP MRA techniques using a blood pool contrast agent in the steady state and comparison to first pass MRA.
    Febbo JA; Galizia MS; Murphy IG; Popescu A; Bi X; Turin A; Collins J; Markl M; Edelman RR; Carr JC
    Eur J Radiol; 2015 Oct; 84(10):1921-9. PubMed ID: 26253499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2D phase contrast blood flow velocity measurements of the thoracic vasculature: comparison of the effect of gadofosveset trisodium and gadopentetate dimeglumine.
    Makowski MR; Wiethoff AJ; Ebersberger HU; Botnar RM; Razavi R; Schaeffter T; Greil GF
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):409-16. PubMed ID: 25385264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single breath-hold assessment of cardiac function using an accelerated 3D single breath-hold acquisition technique--comparison of an intravascular and extravascular contrast agent.
    Makowski MR; Wiethoff AJ; Jansen CH; Uribe S; Parish V; Schuster A; Botnar RM; Bell A; Kiesewetter C; Razavi R; Schaeffter T; Greil GF
    J Cardiovasc Magn Reson; 2012 Jul; 14(1):53. PubMed ID: 22849703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined blood pool and extracellular contrast agents for pediatric and young adult cardiovascular magnetic resonance imaging.
    Johnson JT; Robinson JD; Deng J; Rigsby CK
    Pediatr Radiol; 2016 Dec; 46(13):1822-1830. PubMed ID: 27576457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadofosveset-enhanced MR angiography of carotid arteries: does steady-state imaging improve accuracy of first-pass imaging? Comparison with selective digital subtraction angiography.
    Anzidei M; Napoli A; Marincola BC; Nofroni I; Geiger D; Zaccagna F; Catalano C; Passariello R
    Radiology; 2009 May; 251(2):457-66. PubMed ID: 19401574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-pass and steady-state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium.
    Naehle CP; Müller A; Willinek WA; Meyer C; Hestermann T; Gieseke J; Schild H; Thomas D
    J Magn Reson Imaging; 2009 Oct; 30(4):809-16. PubMed ID: 19787726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MR coronary angiography with MS-325, a blood pool contrast agent: comparison of an inversion recovery steady-state free precession with an inversion recovery fast low angle shot sequence in volunteers].
    Nassenstein K; Waltering KU; Eggebrecht H; Schlosser T; Hunold P; Barkhausen J
    Rofo; 2006 May; 178(5):508-14. PubMed ID: 16586314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unenhanced steady state free precession versus traditional MR imaging for congenital heart disease.
    Chang D; Kong X; Zhou X; Li S; Wang H
    Eur J Radiol; 2013 Oct; 82(10):1743-8. PubMed ID: 23639772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.